Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules

Vaccine

Volumn 16, Issue 7, 1998, Pages 722-726

  Giammanco, Giuseppe ^a   Moiraghi, Angela ^b   Zotti, Carla ^b   Pignato, Sarina ^a   Li Volti, Salvatore ^a   Giammanco, Anna ^c   Soncini, Renato ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Sezione di Microbioiogia   (Italy)

^d SmithKline Beecham SpA   (Italy)

Author keywords

Combined vaccine; Diphtheria; Hepatitis B; Pertussis; Tetanus

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS B VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID;

ANOREXIA; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIPHTHERIA; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FEVER; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFANT; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERTUSSIS; PRIORITY JOURNAL; RESTLESSNESS; TETANUS; VOMITING;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; VACCINES, COMBINED;

EID: 0032053598     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00250-8     Document Type: Article

References (16)

1. 1 André, F.E. Development of combined vaccines: manifacturers' viewpoint. Biologicals 1994, 22, 317-321.
2. 2 Ada, G. Combination vaccines: present practices and future possibilities. Biologicals 1994, 22, 329-331.
3. 3 Miller, D.L., Alderslade, R. and Ross, E.M. Whooping cough and whooping cough vaccine: the risks and benefits debate. Epidemiologic Reviews 1982, 4, 1-24.
4. 4 Howson, C.P., Howe, C.J. and Fineberg, H.V. Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella vaccines. Washington, DC, National Academy Press, 1991.
5. 5 Cherry, J.D. Historical review of pertussis and the classical vaccine. Journal of Infectious Diseases 1996, 174, (Suppl. 3), 259-263.
6. 6 Kimura, M. and Kuno-Sakai, H. Current epidemiology of pertussis in Japan. Pediatric Infectious Disease Journal 1990, 9, 705-709.
7. 7 Greco, D., Salmaso, S. and Mastrantonio, P. et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. New England Journal of Medicine 1996, 334, 341-348.
8. 8 Mortimer, E.A., Kimura, M. Jr and Cherry, J.D. et al. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoid following household exposure of Japanese children. American Journal of Diseases of Children 1990, 144, 899-904.
9. 9 Schmitt, H.J. and Wirsing von Konig, C.H. et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. Journal of the American Medical Association 1996, 275, (1), 37-42.
10. 10 Piazza, M., Da Villa, G. and Picciotto, L. et al. Mass vaccination against Hepatitis B in infants in Italy. Lancet 1988, 2, 1132
11. 11 Giammanco, G., Li Volti, S. and Mauro, L. et al. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy. Vaccine 1991, 9, 747-750.
12. 12 Faldella, G., Alessandroni, R., Fantini, M.P. and Salvioli, G.P. Clinical development of a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine in Italy. Journal of Infectious Diseases 1996, 174, (Suppl. 3), S298-S301.
13. 13 The Italian Vaccine Coverage Survey Working Group. Childhood vaccination coverage in Italy: results of a seven-region survey. Bulletin of the World Health Organization 1994, 72, 885-895
14. 14 Bogaerts, H., Capiau, C., Hauser, P., Mareschal, J.C., Mélot, V. and Simons, D. Overview of the clinical development of a diphtheria - tetanus-acellular pertussis vaccine. Journal of Infectious Diseases 1996, 174, (Suppl. 3), S276-S280.
15. 15 Zepp, F., Schmitt, H.J. and Kaufhold, A. et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. European Journal of Pediatrics 1997, 156, 18-24.
16. 16 Glück, R. Combined vaccines - the European contribution. Biologicals 1994, 22, 347-351.